Engineers Gate Manager LP Ac Immune Sa Transaction History

Engineers Gate Manager LP

  • $4.86 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$5.32 - $8.96 $64,372 - $108,416
-12,100 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$4.47 - $5.58 $54,087 - $67,518
12,100 New
12,100 $63,000
Q2 2020

Aug 17, 2020
SELL
$6.57 - $8.3 $87,978 - $111,145
-13,391 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$4.24 - $9.89 $56,777 - $132,436
13,391 New
13,391 $93,000

Others Institutions Holding ACIU

# of Institutions
48
Shares Held
27.9M
Call Options Held
150K
Put Options Held
12.4K
View Full List

About AC Immune SA

ACIU Quotes by TradingView
  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $218M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email